Light Therapy Buyer’s Guide

ZogniQ ZPL vs InfinityPro vs EPI-C Plus: Which Light-Therapy Platform Is Right for Your Practice?

Three multi-wavelength platforms, three different buyers. Here is how they differ on light delivery, workflow, documentation and practice fit — and which one we would build a new program around.

Build My Light-Therapy Plan → Compare the Three Systems →

Serving practices across Virginia, North Carolina, and South Carolina

On-site demos

Installation & training included

Local support in VA, NC, SC

The Short Answer

Three Platforms, Three Different Buyers

These are the platforms a US eye-care practice is most likely to line up against each other. They overlap. They are not interchangeable.

Our Practice-Building Pick

ZogniQ ZPL

Best overall for building a light-therapy program.

Choose the ZPL if your priority is not simply delivering light, but creating a reproducible session your whole team can run — documented dosimetry, time-of-flight positioning, configurable polarized wavelengths, and integrated 8K pre/post imaging in one platform.

Standalone LLLT

MDelite InfinityPro

A straightforward multi-wavelength LLLT panel.

InfinityPro is a hands-free LED system with a range of visible colors plus infrared. If you want light delivered simply, already own your imaging, and do not need session documentation built into the device, it does that job.

IPL + LLLT Combination

Essilor EPI-C Plus

The option if integrated IPL is essential.

EPI-C Plus is the only one of the three with IPL and LLLT in the same system. If having both modalities under one manufacturer is a hard requirement, it belongs on your shortlist.

How to Frame the Decision

Don’t Ask Which Device Has the Most Lights. Ask Which Practice You Want to Build.

Buying a light-therapy device is the easy part. Building a service patients understand, accept, complete and come back for is the hard part. These are the questions that will still matter in year three:

Can two different techs run the same session the same way?
Can you confirm what energy was actually delivered?
Can you reproduce the setup at the next visit?
Can patients see and understand their own progress?
How many service lines can one capital purchase support?
Does the platform gain capability after you buy it?

Line the three platforms up against those questions and the picture stops being a spec sheet.

Side-by-Side

Platform Comparison

Compiled from each manufacturer’s current published materials. Where a cell reads “not published,” the information was not available in the manufacturer’s public materials — ask the vendor directly.

Scroll the table sideways to see all three platforms →

Feature comparison of ZogniQ ZPL, MDelite InfinityPro and Essilor EPI-C Plus
Category	ZogniQ ZPL	MDelite InfinityPro	Essilor EPI-C Plus
Light delivery
Core modality	Polarized multi-wavelength LED photobiomodulation	Multi-wavelength LED low-level light therapy	LM LLLT plus OPE intense pulsed light
Polarized treatment light	Yes — linearly aligned, patent pending	Not indicated in published materials	Not indicated in published materials
Visible wavelengths	Red, blue, yellow — each polarized	Red, blue, pink, yellow, green	Red, blue, yellow
Infrared	Yes, polarized	Yes	Not a central feature of the current US LLLT positioning
Wavelengths selected individually or combined	Yes, with adjustable intensity and duration	Yes	Protocol and half-mask based
IPL on board	No	No	Yes — the only one of the three
Workflow and documentation
Hands-free session	Yes, contact-free light head	Yes, wraparound LED panels	Yes for the LLLT mask
Per-session dosimetry record	Yes — documented and confirmed each session	Not published	Not published at session level
Distance / positioning sensor	Yes — infrared time-of-flight proximity sensing	Not published	Not published
Energy adjusted for positioning	Yes, per Zognition materials	Not published	Not published
Integrated before/after imaging	Yes — 8K pre and post capture, multiple polarized wavelengths	Not published	No comparable integrated treatment imaging identified
Patient progress visualization	Built into the platform, with image-comparison software	Not published	Typically a separate device and workflow
Connected patient records	Yes	Not published	Not a primary marketed feature
Software / platform updates	Automatic updates and connected support features	Not prominently marketed	Upgradable operating system
Fit
Best practice fit	A documented, reproducible, scalable light-therapy program	Simple standalone LLLT	Programs built around combined IPL and LLLT

Current as of August 2026. Specifications change — confirm current labeling and terms with each manufacturer before a purchase decision.

The Architecture Difference

What ZogniQ Adds Around the Light

Every platform here emits therapeutic light competently. The question is what else is in the box.

Conventional LLLT platform

Light source

Session

Documentation, positioning verification and imaging are handled by your staff, your chart and whatever separate equipment you already own.

ZogniQ ZPL platform

Multi-wavelength polarized light

Documented dosimetry Time-of-flight positioning 8K pre/post imaging Progress tracking Connected records Image-comparison software Automatic updates Remote support

These are the functions that normally live in three or four separate purchases. Bringing them into one platform is the argument.

Our Pick

Why We Give ZogniQ the Edge for a New Program

A protocol is only repeatable when you know what was delivered

Delivered energy falls off with distance, and on most LED platforms nothing measures that distance — so the setting on the screen and the dose at the eyelid are two different numbers. The ZPL documents dosimetry per session and uses infrared time-of-flight sensing to hold device-to-patient positioning. If you are standardizing a protocol across several providers and dozens of repeat visits, that difference compounds every week.

Don’t just deliver the session — document the journey

This may be the most commercially useful thing on the spec sheet. The ZPL captures 8K images before and after each session under multiple polarized wavelengths, with software that lines them up for comparison. Patients decide based on what they can understand. “Your sessions are working because I said so” is a far weaker conversation than a visual record the patient can see. That record supports education, series completion, maintenance plans and the premium feel of the whole encounter — and on the other two platforms, imaging is a separate purchase and a separate workflow.

It is built more like a platform than a lamp

The device you buy today should not be the device you are stuck with in year four. The ZPL is light delivery plus sensing plus imaging plus documentation plus software, with automatic updates and remote diagnostics built into the architecture — so capability can arrive without new hardware. One capital purchase that keeps gaining function is a different ownership proposition than one fixed at the feature set it shipped with.

Polarization is a real engineering differentiator

Polarization is an optical parameter that has drawn genuine scientific attention in photobiomodulation research, with published work suggesting polarized red and near-infrared light may produce different biological activity than otherwise identical non-polarized light. ZogniQ has engineered that property directly into the platform, which sets it apart from conventional unpolarized LED systems. We present it as an engineering differentiator rather than a clinical outcome claim — and pair it with configurable wavelengths, measured delivery and a documented record, which is where the practical advantage actually lives.

Being Straight With You

When One of the Others Is the Better Answer

We would rather tell you this up front than have you find it out after the install.

If you need IPL in the same console

Neither the ZPL nor InfinityPro contains IPL. If having both modalities from one manufacturer on one console is a hard requirement, EPI-C Plus is the platform to look at — and we will say so rather than sell you around it. Budget for its replaceable IPL lamp and treatment masks when you model the cost.

If you want the simplest possible box

If you already own your imaging, do not want session documentation in the device, and want the shortest path to switching on a light, a straightforward LED panel like InfinityPro will do that. The ZPL’s case rests on the documentation and imaging layer — if you genuinely will not use it, you should not pay for it.

Already running IPL? The ZPL is not an either/or against it. It is non-thermal and contact-free with no Fitzpatrick skin-type parameter selection, so practices commonly run a cleared IPL device as the medical arm of the program and polarized light as the comfortable, repeatable, cash-pay arm that keeps patients engaged between and after those series.

Evidence and Regulatory Status

What You Can and Cannot Say About Any of These

Photobiomodulation and low-level light therapy have a substantial and growing published literature, including work in ocular surface disease. But outcomes vary by wavelength, irradiance, fluence, exposure time, treatment frequency and device architecture, which means evidence for photobiomodulation as a modality is not evidence that every PBM device performs identically. Across this category, device-specific ocular clinical trials remain limited — and that includes the ZogniQ ZPL. We are not going to tell you a head-to-head trial exists when it does not.

That is precisely why we weight measured delivery and documentation so heavily. If the literature says results depend on the parameters actually delivered, then knowing what you delivered stops being a nice-to-have.

What “FDA” Actually Means Here

The ZogniQ ZPL is offered within a general wellness framework. It is not FDA-cleared or FDA-approved for the diagnosis or treatment of dry eye disease, meibomian gland dysfunction, or any other medical condition, and nothing on this page is a claim to that effect. MDelite describes InfinityPro as FDA-cleared. EPI-C Plus is cleared under K092734 — a clearance for specified dermatologic indications, not for dry eye or MGD.

None of these three platforms should be described — by us, by a manufacturer, or in your own patient materials — as FDA-approved for dry eye or MGD. If a US authorization specific to dry eye due to MGD is a hard requirement, that is a different shortlist, and we cover it in our ZPL vs OptiLIGHT vs Envision comparison.

The Business Case

Treatments Generate Revenue. Programs Build Practices.

A single light session creates revenue. A structured program creates something more durable: recurring visits, better series completion, ongoing patient education, measurable progress conversations, maintenance plans, and a reason a patient chooses you over the practice four miles away.

That is why our preferred platform is not the one with the longest feature list. It is the one that makes a repeatable patient journey easiest to build — configurable light, documented delivery, positioning technology, integrated imaging and software, in one place. Infrastructure for a program rather than hardware for a procedure.

Model the numbers for your practice

Set your own patients per week, price per session, sessions per series and monthly equipment payment, and see monthly session revenue, net after payment and the break-even patient count.

Open the practice economics calculator →

For practice-planning purposes only. Actual patient volume, pricing, treatment frequency, financing, expenses and profitability vary by practice. No revenue is guaranteed.

Bottom Line

Which Would We Build a New Program Around?

If we were designing a new light-therapy program today and wanted the technology to stay part of the patient experience for years, we would build around the ZogniQ ZPL.

Because treatment capability is only one part of a successful program. You also want documented delivery, repeatable positioning, configurable protocols, visual patient communication, progress documentation, connected records and software that evolves. The ZPL combines more of those elements in one ecosystem than the other platforms compared here.

That recommendation rests on platform architecture, reproducibility, documentation, imaging and patient engagement — the things that determine whether a light-therapy service becomes a program or stays a procedure.

Build My Treatment Revenue Plan

Tell Us What You Want to Build

Tell us what your practice looks like today and what you want it to look like. We will help model the technology, workflow, patient volume and treatment structure that make sense.

See the ZPL in a live demo → Talk to an equipment consultant →

Questions We Get

Frequently Asked Questions

What makes the ZPL different from a conventional LLLT panel?

Three practical differences. Light delivery: a standard LLLT panel emits randomly oriented light, while the ZPL emits linearly aligned polarized light. Configurability: rather than one fixed setting, four wavelengths can be selected and combined at adjustable intensity and duration. Documentation: the ZPL records the dose actually delivered, holds positioning with an infrared time-of-flight sensor, and captures 8K pre- and post-session images. These are design and workflow differences — Carolina Optics does not claim clinical superiority over any other device.

Which of these three includes IPL?

Only EPI-C Plus. It combines Espansione’s OPE intense pulsed light with LM low-level light therapy in a single system. Neither the ZogniQ ZPL nor the MDelite InfinityPro contains IPL — both are LED light platforms. If having IPL and LLLT under one manufacturer is a requirement, EPI-C Plus is the option to look at first.

Can the ZPL work alongside an IPL device I already own?

Yes, and a number of practices run it that way. The ZPL is non-thermal and contact-free, with no Fitzpatrick skin-type parameter selection, so practices commonly use a cleared IPL device as the medical arm of the program and polarized light as the comfortable, repeatable, cash-pay arm that keeps patients engaged between and after those series. If you already own IPL, the ZPL is a complement rather than a replacement — and that changes the economics in your favor.

Is the ZogniQ ZPL FDA-cleared for dry eye?

No. The ZogniQ ZPL is offered within a general wellness framework and is not FDA-cleared or FDA-approved for the diagnosis or treatment of dry eye disease, meibomian gland dysfunction, or any other medical condition. Worth knowing when you compare: neither of the other two platforms on this page carries a US clearance specific to dry eye or MGD either. EPI-C Plus is cleared under K092734 for specified dermatologic indications, and MDelite describes InfinityPro as FDA-cleared.

What does documented dosimetry actually give me?

A record of what was delivered during each session rather than an estimate from the settings. Because delivered energy depends on distance, and the ZPL measures that distance with an infrared time-of-flight sensor, one session becomes genuinely comparable to the next. That is what makes a protocol reproducible between staff members and between visits — and it is what turns the second, third and fourth visit into an easy conversation instead of a sales pitch.

Carolina Optics is an authorized ZogniQ dealer and is not affiliated with, endorsed by, or a distributor for MDelite or Essilor Instruments. Competitor specifications and regulatory details reflect each manufacturer’s published materials and public FDA records, current as of August 2026; confirm current labeling and terms with the manufacturer before relying on them in a purchase decision. ZogniQ™ ZPL is a non-invasive polarized light platform offered within a general wellness framework. It is not FDA-cleared or FDA-approved for the diagnosis or treatment of dry eye disease, meibomian gland dysfunction, or any other medical condition, and nothing on this page is a claim to that effect. Product names and trademarks belong to their respective owners.